Abstract:Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles have attracted an enormous interest for controlled drug delivery. Their clinical applications are, however, partly hindered by lack of biocompatible, biodegradable and functional surfactants. Here, we designed and developed a novel biocompatible surfactant based on amphiphilic vitamin E-oligo(methyl diglycol L-glutamate) (VEOEG) for facile fabrication of robust and tumor-targeting PLGA-based nanomedicines. VEOEG was prepared with controlled M-n of 1.7-2.6 kg/mol and low molecular weight distribution (D = 1.04-1.16) via polymerization of methyl diglycol L-glutamate N-carboxyanhydride using vitamin E-ethylenediamine derivative (VE-NH2) as an initiator. VEOEG had a hydrophile lipophile balance data of 13.8-16.1 and critical micellar concentration of 189.3-203.8 mg/L depending on lengths of oligopeptide. Using VEOEG as a surfactant, PLGA nanoparticles could be obtained via nanoprecipitation method with a small and uniform hydrodynamic size of 135 nm and positive surface charge of +26.6 mV, in accordance with presence of amino groups at the surface. The resulting PLGA nanoparticles could be readily coated with hyaluronic acid (HA) to form highly stable, small-sized (143 nm), monodisperse, and negatively charged nanoparticles (HA-PLGA NPs). Notably, paclitaxel-loaded HA-PLGA NPs (PTX-HA-PLGA NPs) exhibited better antitumor effects in CD44-positive MCF-7 breast tumor cells than Taxol (a clinical paclitaxel formulation). The in vivo pharmacokinetics assay in nude mice displayed that PTX-HA-PLGA NPs possessed a long plasma half-life of 3.14 h. The in vivo biodistribution studies revealed that PTX-HA-PLGA NPs had a high tumor PTX level of 8.4% ID/g, about 6 times better than that of Taxol. Interestingly, therapeutic studies showed that PTX-HA-PLGA NPs caused significantly more effective tumor growth inhibition, better survival rate and lower adverse effect than Taxol. VEOEG has emerged as a versatile and functional surfactant for the fabrication of advanced anticancer nanomedicines.

Ethylene glycol oligomer modified-sodium alginate for efficiently improving the drug loading and the tumor therapeutic effect

Preparation of Liver-targeted Nano-prodrug Based on Sodium Alginate Derivative and the Study on Antitumor Activity

Ionically crosslinked alginate-based nanohydrogels for tumor-specific intracellular triggered release: Effect of chemical modification

QUALITATIVE AND QUANTITATIVE EVALUATION OF GLYCYRRHETINIC ACID MODIFIED ALGINATE LIVER TARGETING DRUG DELIVERY SYSTEMS

Nanogel fabricated from oxidized sodium alginate and hydrophilic-modified chitosan exhibits great potential as pH-responsive drug delivery system

Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.

Immobilization of Coacervate Microcapsules in Multilayer Sodium Alginate Beads for Efficient Oral Anticancer Drug Delivery

Sodium Alginate Conjugated Graphene Oxide As a New Carrier for Drug Delivery System

Carboxymethyl Chitosan-Based Nanogels Via Acid-Labile Ortho Ester Linkages Mediated Enhanced Drug Delivery

Synthesis of polyglycolic acid grafting from sodium alginate through direct polycondensation and its application as drug carrier

Alginic Acid Nanoparticles Prepared Through Counterion Complexation Method As a Drug Delivery System.

Synthesis of alginic acid-poly[2-(diethylamino)ethyl methacrylate] monodispersed nanoparticles by a polymer-monomer pair reaction system.

Preparation of injectable sodium alginate/poloxamer composite hydrogel for sustained drug release

Cytotoxicity of liver targeted drug-loaded alginate nanoparticles

Vitamin E-Oligo(methyl Diglycol L-Glutamate) As a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.

pH-sensitive and tumor-targeting nanogels based on ortho ester-modified PEG for improving the in vivo anti-tumor efficiency of doxorubicin

Preparation and antitumor study of intelligent injectable hydrogel: Carboxymethyl chitosan-aldehyde gum Arabic composite graphene oxide hydrogel

Recent achievements in sodium alginate-based nanoparticles for targeted drug delivery

Galactose-functionalized Multi-Responsive Nanogels for Hepatoma-Targeted Drug Delivery

Alginate-Based Platforms For Cancer-Targeted Drug Delivery

Synthesis, characterization, and drug delivery of amphiphilic poly{(lactic acid)- co -[(glycolic acid)- alt -( L -glutamic acid)]}- g -poly(ethylene glycol)